Skip to main content

Table 1 Characteristics of patients at first stereotactic radiotherapy

From: Radiosurgery or hypofractionated stereotactic radiotherapy for brain metastases from radioresistant primaries (melanoma and renal cancer)

Characteristics of patients (n=60)

Age (Median)[range]

66 years [18–88]

Sex

Female n = 24 (40%) / Male n = 36 (60%)

Histology

Melanoma n = 37 (62%) / Renal cancer n = 23 (38%)

Neurosurgery

Yes n = 15 (25%) / No n = 45 (75%)

Performans status

 0

18 (30%)

 1

33 (55%)

 2

9(15%)

  ≥ 3

0

DS GPA

 4

6 (10%)

 3

17 (28%)

 2

26 (43%)

 1

10 (17%)

 0

1 (2%)

Whole brain radiotherapy

Yes n = 16 (27%)/ No n = 44 (73%)

Time From diagnosis to first stereotactic radiotherapy

Median: 55 days, range [15–1420]

Mean: 109 days, (sd = 200)

Extra-cerebral disease

Yes n = 45 (75%)/ No n = 15 (25%)

Immunotherapy during the course of their disease

Yes n = 21(35%)/ No n = 39 (65%)